Replies to post #241303 on Biotech Values

[dewophile]

That's a risk I can live with - the last buyout by Sumitomo was at a 100% premium.
There is a modicum of shareholder protection insofar as you need a majority of the independent directors to approve the buyout

[semi_infinite]

MYOV - My recollection is that Sumitovant doesn't get to vote their shares in a takeover attempt. Minority share holders have to approve. Is that the way you read it?